QTTB
Q32 Bio Inc.
NASDAQ · Healthcare · Biotechnology · US
$10.54
−2.95%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 470.66x
Trailing multiples
Trailing twelve months
- P/E TTM
- 3.78x
- PEG TTM
- —
- Price / book
- 2.96x
- Price / sales
- 5.84x
- Price / cash flow
- -15.82x
Enterprise value
- Enterprise value
- $212.8M
- EV / sales
- 3.96x
- EV / EBITDA
- 6.15x
- EV / EBIT
- 9.92x
- Market cap
- $313.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026